For Immediate Release
Recognized with annual award in four of the last five years
SCHAUMBURG, Ill.–(BUSINESS WIRE)–Jun. 27, 2013— Sparton Corporation (NYSE: SPA) has again been recognized with honors by the medical design community. The latest award, in the category of In Vitro Diagnostics, was presented at an awards ceremony for the Medical Design Excellence Awards last week as part of the Medical Design & Manufacturing East Conference and Exposition in Philadelphia, Pennsylvania.
The Medical Design Excellence Awards (MDEA) program honors the highest caliber medical devices on the market today and celebrates the achievements of designers, engineers, and manufacturers. The MDEA is an annual awards ceremony that is organized by UBM Canon and recognized throughout the industry for its prestige.
“We are once again excited and proud to stand on the platform in recognition of our contributions as a design team”, commented Dave Lapeus, Director of Design Engineering for Sparton Corporation in Strongsville, Ohio. “It feels great to have been recognized not only this year, but four times out of the last five years. This recognition gives credibility to the emphasis we are placing on design services for Sparton, in addition to our manufacturing services.”
Sparton’s design and engineering services include, but are not limited to, the disciplines of electrical, mechanical and software design with specific emphasis on medical devices in the diagnostic, therapeutic, surgical instrumentation, and laboratory fields.
“Sparton has a proud heritage in the manufacturing of full medical device assemblies, and I am happy to say that we are building a heritage on the design side”, added Mike Gaul, General Manager of Sparton in Strongsville, OH. “It is great to see colleagues in the industry rewarding Sparton for our work and to have the opportunity to move Sparton to the forefront as an organization with quality design capabilities.”
“We focus on the full product lifecycle,” commented Cary Wood, president and CEO. “As Sparton continues to expand its capabilities across the entire Company, design and engineering capabilities continue to be a primary differentiator to our medical & biotechnology customers. This award, and those before it, shows the true capability of our design groups have and we will continue to emphasize our design and manufacturing capabilities as cornerstones of our strategic growth plan”.
For more information on the MDEA awards, including the submission requirements and judging protocol, please visit www.canontradeshows.com/expo/awards.
About Sparton Corporation
Sparton Corporation (NYSE:SPA), now in its 113th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service, and refurbishment. The primary markets served are Medical, Military & Aerospace, and Industrial & Instrumentation. Headquartered in Schaumburg, IL, Sparton currently has five manufacturing locations worldwide. Sparton’s Web site may be accessed at https://www.sparton.com.
Safe Harbor and Fair Disclosure Statement
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in Sparton’s filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton’s services described in Sparton’s filings with the SEC. In particular, see the risk factors described in Sparton’s most recent Form 10K and Form 10Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.
Analyst ContactDon Pearson
Office: (847) 762-5812
Media ContactMike Osborne
Office: (847) 762-5814
Investor ContactJohn Nesbett/Jennifer Belodeau
Institutional Marketing Services
Office: (203) 972-9200